NYVEPRIA Patient Counseling Information (pegfilgrastim-apgf)

Medical Information

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional

I am a U.S. Patient / CaregiverNo, go back to the patient portal

Select I am a U.S. Patient / CaregiverNo, go back to the patient portal

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

17 PATIENT COUNSELING INFORMATION

Advise the patient to read the FDA-approved patient labeling (Patient Information and Instructions for Use).

Advise patients of the following risks and potential risks with NYVEPRIA:

Splenic rupture and splenomegaly
Acute Respiratory Distress Syndrome
Serious allergic reactions
Sickle cell crisis
Glomerulonephritis
Capillary Leak Syndrome
Aortitis

Instruct patients who self-administer NYVEPRIA using the single-dose prefilled syringe of the:

Importance of following the Instructions for Use.
Dangers of reusing syringes.
Importance of following local requirements for proper disposal of used syringes.

This product's label may have been updated. For full prescribing information, please visit www.pfizer.com.

Did you find an answer to your question? Yes No

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

NYVEPRIA Quick Finder

Pfizer samples (for eligible HCPs)

Requests for samples of prescription medications can be made by contacting Pfizer for Professionals at 1-800-505-4426 or by visiting the PfizerPro website www.pfizerpro.com.
Assistance programs (for eligible patients)

Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Patients and physicians can contact RxPathways at (866) 706-2400 or visit the website for more information on these programs www.pfizerrxpathways.com.
Report an adverse event or concern about the quality of a Pfizer product

To report an adverse reaction, or concern about the quality of a Pfizer product, please call Pfizer at 1-800-438-1985 or visit www.fda.gov/medwatch or call FDA at 1-800-332-1088.
Resources

Download Prescribing Information

Did you find an answer to your question? Yes No

Resources

website

Pfizer RxPathways – find information on prescription assistance programs for eligible patients

Didn’t find what you were looking for? Contact us.

Call 800-438-1985^*

*Contact Medical Information. 9AM-5PM ET Monday to Friday; excluding holidays.

Chat Online

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: (800) 438-1985

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch